Response to “Possible dynamic change of CONUT score by pancreatectomy, with special reference to cholesterol and tumor immunity”
23 Oct 2026, 4 p.m.
Publication date: Available online 23 October 2026Source: PancreatologyAuthor(s): Yuki Adachi, ...
Pancreatology Journal, latest articles
Pancreatic cancer risk in people 60 or over with new-onset diabetes and weight loss or pancreatitis
23 Oct 2026, 4 p.m.
Publication date: Available online 23 October 2026Source: PancreatologyAuthor(s):
Role of CFTR gene mutation variants according to the CFTR-France database in idiopathic pancreatitis: does the type matter?
22 Oct 2026, 2 p.m.
Publication date: Available online 21 October 2026Source: PancreatologyAuthor(s): Giovanni Pernigo, ...
Serum Lipase Outperforms Total Serum Amylase as a First-Line Biochemical Test for Suspected Acute Pancreatitis: A Real-World United Kingdom (UK) Cohort Study
21 Oct 2026, 1 p.m.
Publication date: Available online 20 October 2026Source: PancreatologyAuthor(s): Mahmoud Mohamed, ...
Response to Letter to the Editor on “Increased risk of developing diabetes following a sentinel episode of acute pancreatitis in patients with obesity: A propensity matched population study”
20 Oct 2026, noon
Publication date: Available online 19 October 2026Source: PancreatologyAuthor(s): Gordon Hong, ...
Metabolic Dysfunctions in Pancreatic Ductal Adenocarcinoma: Pathogenic Mechanisms and Therapeutic Implications
20 Oct 2026, noon
Publication date: Available online 20 October 2026Source: PancreatologyAuthor(s): Rúben Rodrigues, ...
Albumin in Acute Pancreatitis as a Lipid Scavenger Beyond Volume Replacement
18 Oct 2026, 5 p.m.
Publication date: Available online 17 October 2026Source: PancreatologyAuthor(s): Wataru Kimura
<em>CTRC</em> variant p.Gly60= reduces chymotrypsin C mRNA expression in chronic pancreatitis patients undergoing TPIAT
18 Oct 2026, 5 p.m.
Publication date: Available online 17 October 2026Source: PancreatologyAuthor(s): Gergő Berke, ...
Silencing RNA nanotherapy shows promise against pancreatic cancer
31st Oct 2019
Despite advances in cancer survival, more than 90 percent of people with pancreatic cancer die within five years. Most patients with pancreatic tumors (and half of those with colorectal cancers) carry a mutation in the KRAS gene, which normally controls cell growth and death.
Read more